Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea · Delayed Price · Currency is KRW 1,210.00
-8.00 (-0.66%)
At close: Jun 10, 2026
Aminologics Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 2,259 | 3,522 | -1,620 | 2,436 | -7,282 | 5,360 |
Depreciation & Amortization | 484.02 | 489.49 | 465.43 | 446.15 | 350.84 | 278.81 |
Loss (Gain) From Sale of Assets | - | - | -8.41 | - | - | - |
Asset Writedown & Restructuring Costs | 1,058 | 1,058 | 986 | - | 13,518 | 1,533 |
Loss (Gain) From Sale of Investments | 167.51 | -1,351 | -11.98 | 101.82 | 659.69 | -658.99 |
Other Operating Activities | 2,562 | 2,218 | 3,625 | 1,464 | 1,951 | -1,327 |
Change in Accounts Receivable | -133.98 | -3,053 | 3,878 | -2,929 | 836.43 | -1,595 |
Change in Inventory | 335.73 | 937.87 | -1,441 | -1,102 | -2,592 | -1,725 |
Change in Accounts Payable | 419.16 | -1,621 | 1,810 | -898.1 | -2,124 | 95.95 |
Change in Unearned Revenue | 22.9 | 22.42 | 17.12 | - | - | - |
Change in Other Net Operating Assets | 453.34 | 317.73 | -233.39 | 263.03 | -91.77 | -1,026 |
Operating Cash Flow | 7,628 | 2,541 | 7,466 | -218.15 | 5,226 | 935.52 |
Operating Cash Flow Growth | 328.04% | -65.97% | - | - | 458.64% | -47.09% |
Capital Expenditures | -75.7 | -45.7 | -511.5 | -155.8 | -490.2 | -515.71 |
Sale (Purchase) of Intangibles | - | - | 41.39 | - | -13 | -17.6 |
Sale (Purchase) of Real Estate | - | - | - | - | - | -128.58 |
Investment in Securities | -18,552 | -14,762 | - | - | -331.79 | 5.4 |
Other Investing Activities | 0 | 0 | 4.42 | - | - | 12.77 |
Investing Cash Flow | -18,627 | -14,807 | -465.69 | -155.8 | -834.98 | -632.38 |
Long-Term Debt Issued | - | 19,932 | - | - | - | - |
Long-Term Debt Repaid | - | -226.93 | -227.13 | -223.92 | -191.39 | -164.11 |
Total Debt Repaid | -226.61 | -226.93 | -227.13 | -223.92 | -191.39 | -164.11 |
Net Debt Issued (Repaid) | 19,705 | 19,705 | -227.13 | -223.92 | -191.39 | -164.11 |
Financing Cash Flow | 19,705 | 19,705 | -227.13 | -223.92 | -191.39 | -164.11 |
Foreign Exchange Rate Adjustments | 612.96 | 135.6 | 110.44 | -141.9 | -322.82 | 142.09 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | - | - | - |
Net Cash Flow | 9,318 | 7,574 | 6,884 | -739.77 | 3,877 | 281.11 |
Free Cash Flow | 7,552 | 2,495 | 6,955 | -373.95 | 4,736 | 419.81 |
Free Cash Flow Growth | 493.24% | -64.13% | - | - | 1028.11% | -71.24% |
Free Cash Flow Margin | 33.30% | 11.33% | 41.42% | -1.79% | 17.32% | 1.84% |
Free Cash Flow Per Share | 85.34 | 28.41 | 77.27 | -4.26 | 53.92 | 4.78 |
Cash Interest Paid | 55.83 | 58.92 | 64.4 | 40.26 | 20.82 | 12.7 |
Cash Income Tax Paid | - | -9.95 | 44.94 | 77.24 | 37.59 | -15.25 |
Levered Free Cash Flow | 11,015 | 6,504 | 5,833 | -2,002 | 819.11 | -1,572 |
Unlevered Free Cash Flow | 11,928 | 7,119 | 5,885 | -1,966 | 844.12 | -1,553 |
Change in Working Capital | 1,097 | -3,396 | 4,030 | -4,666 | -3,972 | -4,250 |